Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Curaxis Pharmaceutical Corp (CURX.PK) since 2011 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Curaxis Pharmaceutical Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1434893.
Total stock buying since 2011: $30,000.
Total stock sales since 2011: $389,000.
Total stock option exercises since 2011: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2011 | 600,000 | $30,000 | 6,420,000 | $389,000 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2011-11 | 0 | $0 | 1,650,000 | $82,500 | 0 | $0 |
| 2011-10 | 100,000 | $5,000 | 2,870,000 | $164,000 | 0 | $0 |
| 2011-09 | 100,000 | $5,000 | 0 | $0 | 0 | $0 |
| 2011-08 | 400,000 | $20,000 | 1,900,000 | $142,500 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-11-02 | Smith Patrick S (10% Owner) | Sale | 1,650,000 | .05 | 82,500 |
| 2011-10-11 | Smith Patrick S (10% Owner) | Sale | 820,000 | .05 | 41,000 |
| 2011-10-10 | George Michael W (Director) | Buy | 100,000 | .05 | 5,000 |
| 2011-10-03 | Smith Patrick S (10% Owner) | Sale | 2,050,000 | .06 | 123,000 |
| 2011-09-16 | Leary Stephen J (Director) | Buy | 100,000 | .05 | 5,000 |
| 2011-08-15 | Leary Stephen J (Director) | Buy | 200,000 | .05 | 10,000 |
| 2011-08-15 | Geaslen Judith S.t. (VP - Finance) | Buy | 200,000 | .05 | 10,000 |
| 2011-08-15 | Smith Patrick S (10% Owner) | Sale | 1,900,000 | .07 | 142,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of CURX.PK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Curaxis Pharmaceutical Corp (symbol CURX.PK, CIK number 1434893) see the Securities and Exchange Commission (SEC) website.